Published in J Neurochem on January 01, 1984
A prospective study of acute idiopathic neuropathy. III. Immunological studies. J Neurol Neurosurg Psychiatry (1988) 0.97
A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry (1989) 0.94
De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease. Brain (2016) 0.80
The differentiation of peripheral effector neuron failure from acute brain stem dysfunction in a critically ill patient. J Neurol Neurosurg Psychiatry (1992) 0.75
Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med (1995) 5.73
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Controlled trial prednisolone in acute polyneuropathy. Lancet (1978) 3.71
Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature (1978) 3.29
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation (1990) 2.74
A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry (1988) 2.63
A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry (1988) 2.56
Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry (1997) 2.52
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology (Oxford) (2004) 2.37
Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol Microbiol (2000) 2.28
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol (1999) 2.08
Epidemiological study of Guillain-Barré syndrome in south east England. J Neurol Neurosurg Psychiatry (1998) 2.07
The psychometric properties of clinical rating scales used in multiple sclerosis. Brain (1999) 2.06
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler (1999) 2.02
Imaging in transient regional osteoporosis. Br J Rheumatol (1997) 2.01
Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med (1991) 2.01
Relapsing polychondritis. Three cases with a clinico-pathological study and literature review. Q J Med (1972) 1.87
Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. Mol Microbiol (2000) 1.85
Overview of azathioprine treatment in multiple sclerosis. Lancet (1991) 1.83
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the adult mouse. J Cell Sci (1971) 1.82
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med (2001) 1.69
Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med (1993) 1.67
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother (1991) 1.67
Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide. Mol Microbiol (2000) 1.66
A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain (2004) 1.62
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2000) 1.62
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int (2000) 1.62
Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol (1995) 1.60
Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med (1990) 1.57
Trigeminal sensory neuropathy. A study of 22 cases. Brain (1987) 1.56
Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med (2000) 1.55
Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry (2000) 1.50
Guillain-Barré syndrome after treatment with streptokinase. BMJ (1992) 1.48
A case of fatal peri-partum cardiomyopathy. Br Heart J (1970) 1.46
Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet (1984) 1.43
Acute inflammatory polyneuropathy. Br J Hosp Med (1978) 1.42
Nosocomial febrile illnesses in patients on an internal medicine service. Arch Intern Med (1989) 1.41
Vasculitic neuropathy in association with chronic graft-versus-host disease. J Neurol Sci (1999) 1.41
Clinical scales for multiple sclerosis. J Neurol Sci (1996) 1.39
Chronic relapsing axonal neuropathy: a first case report. Ann Neurol (1995) 1.38
Intravenous IgG in Guillain-Barré syndrome. BMJ (1996) 1.38
The chemical composition of vertebrate myelin and microsomes. J Neurochem (1965) 1.37
The effects of methotrexate on pregnancy, fertility and lactation. QJM (1999) 1.36
Prognosis in Guillain-Barré syndrome. Lancet (1985) 1.33
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain (2001) 1.32
Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J Cell Biol (1991) 1.30
Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol (1999) 1.28
Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry (1999) 1.27
The course of patients with suspected myocardial infarction. The identification of low-risk patients for early transfer from intensive care. N Engl J Med (1980) 1.27
Plasma exchange for Guillain-Barré syndrome. Br Med J (Clin Res Ed) (1985) 1.24
The susceptibility of rat strains to experimental allergic encephalomyelitis. Immunology (1973) 1.23
Identification of the neuritogen for experimental allergic neuritis. Nature (1979) 1.21
Reliability of distance estimation by doctors and patients: cross sectional study. BMJ (1998) 1.21
Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev (2002) 1.20
Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol (1991) 1.19
Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus--nerve biopsy and response to plasma exchange. J Neurol (1982) 1.19
Ciliary neurotrophic factor. J Neurobiol (1994) 1.17
Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barré syndrome). Clin Exp Immunol (1983) 1.17
An assessment of disability rating scales used in multiple sclerosis. Arch Neurol (1991) 1.16
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies. Neurology (2004) 1.15
Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein,P2. Brain Res (1980) 1.14
Mixed or immune complex cryoglobulinaemia and neuropathy. J Neurol Neurosurg Psychiatry (1974) 1.13
Acute necrotic myelopathy with pulmonary tuberculosis. Brain (1977) 1.12
Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab (1998) 1.11
A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review. Brain (1991) 1.11
MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry (1993) 1.09
Microangiopathy of vasa nervorum in dysglobulinemic neuropathy. Ann Neurol (1984) 1.07
Sterilization of instruments in isolated hospitals. Trop Doct (1982) 1.07
Prospects for the treatment of multiple sclerosis. J R Soc Med (1991) 1.07
Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome. Q J Med (1988) 1.06
T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology (1990) 1.06
Intellectual impairment in neurofibromatosis 1. J Neurol Sci (1996) 1.04
A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol (1996) 1.03
HLA-B27 subtypes in the spondarthropathies. Clin Exp Immunol (1993) 1.03
The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol (1991) 1.02
HLA antigens in the Guillain-Barré syndrome. J Neuroimmunol (1988) 1.01
Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord. Immunology (1974) 1.01
Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome. Clin Exp Immunol (1989) 1.01
HLA antigens in Guillain-Barré syndrome. Lancet (1977) 1.00
Immunological mechanisms of demyelination. J R Soc Med (1992) 0.98
A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization. J Biol Chem (1989) 0.98
Plasma exchange versus intravenous immunoglobulin for Guillain-Barré syndrome. Ther Apher (1997) 0.98
Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev (2001) 0.98
Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol (2000) 0.97
Scale development and Guy's Neurological Disability Scale. J Neurol (1999) 0.97
A comparative study of brain and liver mitochondria from new-born and adult rats. J Neurochem (1969) 0.97